Download PDF
Thromb Haemost 2002; 87(03): 364-365
DOI: 10.1055/s-0037-1613012
Commentary
Schattauer GmbH

P-selectin and PSGL-1: Exploiting Connections Between Inflammation and Venous Thrombosis

Rodger P. McEver
1   Warren Medical Research Institute and Department of Medicine, Department of Biochemistry and Molecular Biology, Oklahoma Center for Medical Glycobiology, University of Oklahoma Health Sciences Center; and Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
14 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Esmon CT. Role of coagulation inhibitors in inflammation. Thromb Haemost 2001; 86: 51-6.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation 2001; 103: 1718-20.
    CrossrefPubMedGoogle Scholar
  • 3 Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, Greenfield L, Wakefield T. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb Haemost 2002; 87: 374-82.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-56.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Bouchard BA, Tracy PB. Platelets, leukocytes, and coagulation. Curr Opin Hematol 2001; 08: 263-9.
    CrossrefPubMedGoogle Scholar
  • 6 McEver RP, Cummings RD. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 1997; 100: 485-92.
    CrossrefPubMedGoogle Scholar
  • 7 Leppänen A, Mehta P, Ouyang Y-B, Ju T, Helin J, Moore KL, van Die I, Canfield WM, McEver RP, Cummings RD. A novel glycosulfopeptide binds to P-selectin and inhibits leukocyte adhesion to P-selectin. J Biol Chem 1999; 274: 24838-48.
    CrossrefPubMedGoogle Scholar
  • 8 Leppänen A, White SP, Helin J, McEver RP, Cummings RD. Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues. J Biol Chem 2000; 275: 39569-78.
    CrossrefPubMedGoogle Scholar
  • 9 Somers WS, Tang J, Shaw GD, Camphausen RT. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and Eselectin bound to SLe(X) and PSGL-1. Cell 2000; 103: 467-79.
    CrossrefPubMedGoogle Scholar
  • 10 Ramachandran V, Yago T, Epperson TK, Kobzdej MMA, Nollert MU, Cummings RD, Zhu C, McEver RP. Dimerization of a selectin and its ligand stabilizes cell rolling and enhances tether strength in shear flow. Proc Natl Acad Sci USA 2001; 98: 10166-71.
    CrossrefPubMedGoogle Scholar
  • 11 Patel KD, Nollert MU, McEver RP. P-selectin must extend a sufficient length from the plasma membrane to mediate rolling of neutrophils. J Cell Biol 1995; 131: 1893-902.
    CrossrefPubMedGoogle Scholar
  • 12 Setiadi H, Sedgewick G, Erlandsen SL, McEver RP. Interactions of the cytoplasmic domain of P-selectin with clathrin-coated pits enhance leukocyte adhesion under flow. J Cell Biol 1998; 142: 859-71.
    CrossrefPubMedGoogle Scholar
  • 13 Schmidtke DW, Diamond SL. Direct observation of membrane tethers formed during neutrophil attachment to platelets or P-selectin under physiological flow. J Cell Biol 2000; 149: 719-29.
    CrossrefPubMedGoogle Scholar
  • 14 Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Invest 1996; 98: 1699-702.
    CrossrefPubMedGoogle Scholar
  • 15 Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 2001; 154: 485-90.
    CrossrefPubMedGoogle Scholar
  • 16 Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
    CrossrefPubMedGoogle Scholar
  • 17 Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-5.
    PubMedGoogle Scholar
  • 18 André P, Hartwell D, Hrachovinová I, Saffaripour S, Wagner DD. Procoagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000; 97: 13835-40.
    CrossrefPubMedGoogle Scholar
  • 19 Toombs CF, DeGraaf CL, Martin JP, Geng JG, Anderson DC, Shebuski RJ. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 1995; 275: 941-9.
    PubMedGoogle Scholar
  • 20 Kumar A, Villani MP, Patel UK, Keith Jr. JC, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999; 99: 1363-9.
    CrossrefPubMedGoogle Scholar
  • 21 Wakefield TW, Strieter RM, Downing LJ, Kadell AM, Wilke CA, Burdick MD, Wrobleski SK, Phillips ML, Paulson JC, Anderson DC, Greenfield LJ. P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 1996; 64: 26-31.
    CrossrefPubMedGoogle Scholar
  • 22 Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ. Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 1997; 25: 816-27.
    CrossrefPubMedGoogle Scholar
  • 23 Eppihimer MJ, Schaub RG. P-selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol 2000; 20: 2483-8.
    CrossrefPubMedGoogle Scholar
  • 24 Myers DD, Schaub R, Wrobleski SK, Londy FJI, Fex BA, Chapman AM, Greenfield LJ, Wakefield TW. P-selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost 2001; 85: 423-429.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Hull RD, Raskob GE, Pineo GF, Green D, Trowbridge AA, Elliott CG, Lerner RG, Hall J, Sparling T, Brettell HR. et al. Subcutaneous low-molecularweight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis. N Engl J Med 92; 326: 975-82.
    PubMedGoogle Scholar
  • 26 Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, Ginsberg J, Turpie AG, Demers C, Kovacs M. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 96; 334: 677-81.
    PubMedGoogle Scholar
  • 27 Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecularweight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 99; 130: 800-9.
    PubMedGoogle Scholar